Business

agilon health Reports Fourth Quarter and Full Year Fiscal 2025 Results

WESTERVILLE, Ohio, February 25, 2026--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the fourth quarter and fiscal year ended December 31, 2025.

articleAgilon Health, Inc.February 25, 202624/company/agilon-health-inc/news/agilon-health-reports-fourth-quarter-and-full-year-fiscal-2025-results
agilon health Reports Fourth Quarter and Full Year Fiscal 2025 Results

About this update from Agilon Health, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1281,"height":200,"url":"https://media.zenfs.com/en/business-wire.com/975604936b29bdf92c529445f8925403"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/u28hX6iKE1WxAHbAdNaoYQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE1MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/975604936b29bdf92c529445f8925403","width":960,"height":150},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/2RZCafTgy2agPG5m8FxMig--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0zNzQ7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/975604936b29bdf92c529445f8925403","width":1200,"height":187}},"lazy":false},{"type":"text","content":"Issues 2026 Guidance Highlighting Expected Breakeven Adjusted EBITDA Midpoint","length":77,"tagName":"p","attribs":{}},{"type":"text","content":"WESTERVILLE, Ohio, February 25, 2026--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the fourth quarter and fiscal year ended December 31, 2025.","length":262,"tagName":"p"},{"type":"text","content":""2025 was a pivotal year for agilon. We confronted challenges head-on and focused our actions to accelerate meaningful transformation across the company — enhancing execution, improving operating discipline, and fundamentally strengthening the economics of our model," stated Ronald A. Williams, Executive Chair. "While we were not satisfied by our 2025 financial performance, the transformation initiatives are delivering tangible benefits which support our expectation for material improvement in 2026. Based on the progress we have made and the momentum we are carrying into 2026, I am confident in our trajectory and firmly believe agilon and our partners are entering the next phase with a stronger foundation, a more resilient model, and a clear path to sustainable value creation."","length":808,"tagName":"p"},{"type":"text","content":"Fourth Quarter and Fiscal Year 2025 Results:","length":44,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Total members on the agilon platform decreased to 625,000 as of December 31, 2025, comprising 511,000 Medicare Advantage members and 114,000 ACO model beneficiaries. Ye...

More updates from Agilon Health, Inc.

Medicare AdvantageGross ProfitTotal revenuefourth quarterEBITDAAdjusted EBITDAhealth care